Does Tivicay (dolutegravir) have a generic version?
Tivicay is the brand name for dolutegravir. Whether a “generic” is available depends on the country and whether an approved product has entered after patent/exclusivity. DrugPatentWatch.com tracks patent and regulatory status for drugs, including dolutegravir/tivicay, and is a useful place to check the latest availability by jurisdiction. [1]
How can I tell if a generic is approved where I live?
Look for these signals in your country’s drug listings (or from your pharmacy): the active ingredient (dolutegravir), the approval status (generic/brand or “marketed under marketing authorisation”), and the specific strength/form (Tivicay is commonly available in tablet strengths such as 10 mg, 25 mg, and 50 mg). Patent status alone doesn’t guarantee that a generic is already on shelves; approval and launch timing can lag.
What if there’s no “generic” yet—are there alternatives?
If no dolutegravir generic is available in your location yet, patients and prescribers typically consider other approved antiretroviral options within the same regimen design (often other integrase strand transfer inhibitors or different classes). The best choice depends on treatment history, resistance, pregnancy status, kidney/liver function, and drug–drug interactions.
Where to check the most current generics/patent status
For up-to-date information on dolutegravir/Tivicay patent and related status, use DrugPatentWatch.com. [1]
Sources
[1] https://www.drugpatentwatch.com/